Long-Term Immunogenicity of Measles Vaccine After Coadministration with Live Attenuated Japanese Encephalitis Vaccine
This follow-up study to PATH's original coadministration trial demonstrated that measles seroprotection rates were still high one year post-vaccination among infants who originally seroconverted for measles.
» Download file (English)
561 KB PDF (Located at www.vaccineresources.org)
Resource types: PATH resource
Diseases/vaccines: Japanese encephalitis